Click
Here
for more articles |
|
|
Doctors
make life saving discovery for patients
with coronary artery diseaseMajor study
shows addition of widely used agent to
treatment can prevent 50,000 heart attacks
and deaths in Canada |
by:
NC |
Major study shows addition of widely used
agent to treatment can prevent 50,000 heart
attacks and deaths in Canada
(NC)—Cardiovascular disease remains the
leading killer in Canada. In fact, one in
five of all deaths each year are from coronary
artery disease, the most common manifestation
of heart disease. Despite medical advances,
far too many men and women continue to die
prematurely from this deadly disease. Many
people may know they have coronary disease
yet feel quite well until suddenly they
are struck down by a heart attack. New treatment
strategies are badly needed.
Common
heart pill enhances survival hopes
An important international heart study
published in the prestigious medical journal
The Lancet, showed that patients with
coronary artery disease who add the safe
and inexpensive blood pressure drug perindopril
(Coversyl®) to their existing treatment
can significantly reduce their risk of
heart attacks and heart related deaths.
In fact, perindopril (Coversyl®) reduced
the risk of heart attacks and death by
20 per cent even in patients considered
relatively low risk. "This is a major
step forward and will have important implications
in the future management of coronary disease"
said Dr. Jean-Claude Tardif, Director
of Clinical Research, Associate Professor
of Medicine, Montreal Heart Institute.
"For the first time we have a drug that
not only treats hypertension (high blood
pressure), but also improves the outcome
of patients with coronary disease."
Researchers estimated that the addition
of perindopril could prevent 50,000 heart
attacks and deaths in Canada over the
next four years. The doctors concluded
that, "treatment with perindopril, on
top of other preventive medications should
be considered in all patients with coronary
heart disease."
For more information, talk to your doctor
or visit www.europa-trial.org.
- News Canada
About the author:
News Canada
Circulated by Bandoni
Media
|
|
